First Malaria Treatment Specifically for Babies Approved for Rollout in Africa
The first malaria treatment specifically formulated for babies and very young children has been approved and is set to be rolled out across African countries in the coming weeks. Known as Coartem Baby (or Riamet Baby in some regions), the drug was developed by Novartis in partnership with the Medicines for Malaria Venture (MMV), a Swiss-based non-profit supported by governments...
